Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Virpax Pharmaceuticals Inc 1055 Westlakes Drive Suite 300 Berwyn PA 19312 USA

www.virpaxpharma.com P: 610-727-4597

Description:

Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. It is focused on pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax Pharmaceuticals Inc. is based in WEST CHESTER, PA.

Key Statistics

Overview:

Market Capitalization, $K 2,916
Enterprise Value, $K -6,224
Shares Outstanding, K 1,171
Annual Sales, $ 0 K
Annual Net Income, $ -15,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,560 K
EBIT, $ -15,690 K
EBITDA, $ -15,690 K
60-Month Beta 1.56
% of Insider Shareholders 6.23%
% of Institutional Shareholders 32.23%
Float, K 1,098
% Float 93.77%
Short Volume Ratio 0.50

Growth:

1-Year Return -66.16%
3-Year Return -93.60%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.10 on 11/15/23
Latest Earnings Date 05/10/24 [--]
Earnings Per Share ttm -9.10
EPS Growth vs. Prev Qtr -88.89%
EPS Growth vs. Prev Year 21.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/01/24

VRPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -169.04%
Return-on-Assets % -106.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.40
Book Value/Share 1.65
Interest Coverage -0.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar